View in EDS

Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].

Saved in:
Bibliographic Details
Title: Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
Authors: Kim SH; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States. Electronic address: soonghoon.kim@bms.com., Johnson JA; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Jiang J; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Parkhurst B; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Phillips M; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Pi Z; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Qiao JX; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Tora G; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Ye Chen A; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Liu E; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Yin X; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Yang R; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Zhao L; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Taylor DS; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Basso M; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Behnia K; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Onorato J; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Chen XQ; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Abell LM; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Lu H; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Locke G; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Caporuscio C; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Adam LP; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Gordon D; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Wexler RR; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States., Finlay HJ; Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States.
Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Sep 01; Vol. 29 (17), pp. 2525. Date of Electronic Publication: 2019 Jul 25.
Publication Type: Published Erratum
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1464-3405
DOI:10.1016/j.bmcl.2019.07.032